May 18, 2020 / 12:05 PM / 15 days ago

BRIEF-Agilent PD-L1 Assay Receives FDA Approval For Use As Companion Diagnostic

May 18 (Reuters) - Agilent Technologies Inc:

* AGILENT PD-L1 ASSAY RECEIVES FDA APPROVAL FOR USE AS A COMPANION DIAGNOSTIC

* AGILENT PD-L1 ASSAY RECEIVES FDA APPROVAL FOR USE AS A COMPANION DIAGNOSTIC

* AGILENT TECHNOLOGIES INC - ASSAY WILL HELP GUIDE TREATMENT DECISIONS IN CASES OF NON-SMALL CELL LUNG CANCER Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below